David R Coghill (David C Coghill, David Coghill)

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 11

Top Venues

CNS drugs

European child & adolescent psychiatry

Science advances

Journal of consulting and clinical psychology

University of Melbourne

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Melbourne Feb 1o 2016

Australia

Professor :: Medicine, Dentistry and Health Sciences

Publications

Elizabeth Bowman, David R Coghill, Carsten Murawski, Peter Bossaerts
Not so smart? "Smart" drugs increase the level but decrease the quality of cognitive effort. Science advances 9 (24) (2023)
Leanne Winter, Hedwig J Goijen, Vanessa E Cobham, William Bor, Stephen S Stathis, David R Coghill, Christel M Middeldorp
The impact of COVID-19 on children and adolescents attending Child and Youth Mental Health Services in Queensland, Australia. Early intervention in psychiatry (2023)
Daniel P Sullivan, Leanne Winter, Kelsie Ann Boulton, Natalie Silove, Mark A Bellgrove, Nardia Zendarski, David R Coghill, Adam John Guastella, Christel M Middeldorp
Examining the pharmacological and psychological treatment of child and adolescent ADHD in Australia: Protocol for a retrospective cohort study using linked national registry data. BMJ open 12 (11) (2022)
Han Eol Jeong, Hyesung Lee, Edward Chia-Cheng Lai, Tzu-Chi Liao, Kenneth K C Man, Ian Chi Kei Ck Wong, David R Coghill, Mei-Hung Chi, Cheng-Yang Hsieh, Ju Young Shin
Association between methylphenidate and risk of myocardial infarction: A multinational self-controlled case series study. Pharmacoepidemiology and drug safety 30 (10) (2021)
Iris Merith E Idema, Jonathan M Payne, David R Coghill
Effects of methylphenidate on cognitive functions in boys with attention deficit hyperactivity disorder: Does baseline performance matter? Journal of consulting and clinical psychology 89 (7) (2021)
Le Gao, Kenneth K C Man, Esther Wai Yin Chan, Celine Sze Ling Chui, Xue Li, David R Coghill, Kam Lun Ellis Hon, Man Li Tse, Terry Yat-Sang Lum, Kirstie H T W Wong, Patrick Ip, Ian Chi Kei Ck Wong
Treatment with Methylphenidate for Attention Deficit Hyperactivity Disorder (ADHD) and the Risk of All-Cause Poisoning in Children and Adolescents: A Self-Controlled Case Series Study. CNS drugs 35 (7) (2021)
David R Coghill, Yasong Du, Wenqing Jiang, null Xian, Dali Lu, Yun Qian, Melissa Mulraney, Linyang Su
A novel school-based approach to screening for attention deficit hyperactivity disorder. European child & adolescent psychiatry (2021)
Samuele Cortese, Jeffrey H Newcorn, David R Coghill
A Practical, Evidence-informed Approach to Managing Stimulant-Refractory Attention Deficit Hyperactivity Disorder (ADHD). CNS drugs 35 (10) (2021)
David R Coghill, Jeffrey H Newcorn, Jie Chen, Tamara Werner-Kiechle, Tobias Banaschewski
Post hoc analyses of response rates to pharmacological treatments in children and adolescents with attention-deficit/hyperactivity disorder. Journal of psychopharmacology (Oxford, England) 34 (8) (2020)
David R Coghill, Tamara Werner-Kiechle, Sepehr Farahbakhshian, Caleb Bliss, Brigitte Robertson, Michael Huss
Functional impairment outcomes in clinical trials of different ADHD medications: post hoc responder analyses and baseline subgroup analyses. European child & adolescent psychiatry 30 (5) (2020)
David R Coghill, Tobias Banaschewski, Caleb Bliss, Brigitte Robertson, Alessandro Zuddas
Cognitive Function of Children and Adolescents with Attention-Deficit/Hyperactivity Disorder in a 2-Year Open-Label Study of Lisdexamfetamine Dimesylate. CNS drugs 32 (1) (2019)

David R Coghill.css-eqlu8i{font-size:small;padding-left:4px;} (David C Coghill, David Coghill)

Publication Activity (10 Years)

Top Topics

Top Venues

David R Coghill (David C Coghill, David Coghill)